Abstract:A series of novel O-((3-arylisoxazol-5-yl) methyl) oxime derivatives were synthesized by highly regioselective dipolar cycloadditions of nitrile oxides with (E)-1-arylethan-1-one O-prop-2-yn-1-yl oxime substrates. Results showed that in the formation of (E)-N-hydroxy-3,4-dimethoxybenzimidoyl chloride, chlorinating substitution in phenyl occurred when excess N-chlorosuccinimide. The crystal structure of 10 among the series of compounds revealed it was cis-cyclization product and moiety of -C(CH3)=N-O- was E configuration. As a triclinic crystal, the twist angle between the isoxazol-5-yl ring (B) and phenyl ring (A) was 57.43°, at dihedral angles of 25.22°. Screening for anti-HBV activities of these compounds was carried out. The results showed compounds 11, 19 and 12 effectively inhibited HBeAg (IC50 =158.28± 0.02, 127.51± 0.01, and 213.26± 0.04 respectively). Compounds 11, 19 and 23 manifested stronger inhibition on HBsAg (IC50=12.68± 0.06, 61.24± 0.02, and 89.59± 0.02 μM respectively). Compound 15 was the effctivest inhibition of DNA replication (IC50=43.52±0.02 μM) among the compounds. Docking study of bioactive compounds with HBV core protein (3KXS) was carried out to explore their interaction.This study determined a new non-nucleoside analogs with inhibition of HBV.

Design, Synthesis and Inhibitory Properties Against Coxsackie B3/B6 of Some Novel Triazole Derivatives

Synthesis, Characterization, and Biological Evaluation of Novel 7-Oxo-7H-thiazolo[3,2-b]-1,2,4-triazine-2-carboxylic Acid Derivatives

Design, synthesis, and antiviral activities evaluation of novel quinazoline derivatives containing sulfonamide moiety

Synthesis, structure characterization, and biological evaluation of some new 1,2,3-benzotriazole derivatives

AVIAN POX INFECTION IN AN AMERICAN GREEN-WINGED TEAL (Anas crecca carolinensis) IN ALASKA

Design, synthesis, and in vitro evaluation of novel antifungal triazoles containing substituted 1,2,3-triazole-methoxyl side chains

Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains.

Design, synthesis and in vitro biological studies of novel triazoles with potent and broad-spectrum antifungal activity

Design, synthesis, antifungal evaluation, and molecular docking of novel 1,2,4-triazole derivatives containing oxime ether and cyclopropyl moieties as potential sterol demethylase inhibitors

Design, synthesis, and biological evaluation of novel (E)-1-arylethan-1-one O-((3-arylisoxazol-5-yl) methyl) oxime derivatives as potent non-nucleoside HBV inhibitors

Synthesis and Antimicrobical Evaluation of a Novel Class of 1,3,4-Thiadiazole: Derivatives Bearing 1,2,4-Triazolo[1,5-a]pyrimidine Moiety.

Synthesis and antiviral bioactivity of novel 3-((2-((1E,4E)-3-oxo-5-arylpenta-1,4-dien-1-yl)phenoxy)methyl)-4(3H)-quinazolinone derivatives.

Flow rate nomograms in 7‐ to 16‐year‐old healthy children

Synthesis and Antiviral Activity of New Dimeric 1,2,3-Triazolyl Pyrimidine Nucleoside Analogues

Synthesis and antifungal evaluation of 1,2,4-triazolo[1,5-α] pyrimidine bearing 1,2,4-triazole heterocycle derivatives

Syntheses, Characterizations, and Inhibition Activities Against Coxsackievirus B3 of Iodobenzoic Hydrazide Functionalized Hexamolybdates

Synthesis, Molecular Docking, and Biological Evaluation of Novel Triazole Derivatives as Antifungal Agents

Synthesis and Anti-Hiv Activity of Triazolo-fused 3′,4′-Cyclic and 4′-Spiro Nucleoside Analogues

Synthesis, Anti-Tomato Spotted Wilt Virus Activities, and Interaction Mechanisms of Novel Dithioacetal Derivatives Containing a 4(3H)-Quinazolinone Pyrimidine Ring.

Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.

Synthesis and biological evaluation of 3,4-diaryl-5-aminoisoxazole derivatives.